Stoke Therapeutics Inc (STOK)

Financing Cash Flow

$181.70M

TTM · Period ending: · USD

STOK logo

STOK Financing Cash Flow

Latest reported$181.70M
STOK TTM Cash from Financing ($115.64M → $181.70M)
High-resolution chart · PNG

STOK financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Stoke Therapeutics Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
181,700,000
180,342,000
97,389,000
5,616,000
10,655,000
130,751,000
131,094,000
137,869,000
130,272,000
9,670,000
53,007,000
45,707,000
45,579,000
48,956,000
46,409,000
46,537,000
46,511,000
43,245,000
1,284,000
107,981,000
108,246,000
108,456,000
108,108,000
1,432,000
-241,000
150,028,000
149,762,000
239,349,000
253,727,000
103,152,000
115,639,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.